PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-74.48%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-74.48%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
148.53%
EBIT growth below 50% of JHX's 386.17%. Michael Burry would suspect deeper competitive or cost structure issues.
148.53%
Operating income growth 1.25-1.5x JHX's 123.19%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
-87.47%
Negative net income growth while JHX stands at 43.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
118.03%
Similar 10Y revenue/share CAGR to JHX's 117.83%. Walter Schloss might see both firms benefiting from the same long-term demand.
80.30%
5Y revenue/share CAGR above 1.5x JHX's 48.10%. David Dodd would look for consistent product or market expansions fueling outperformance.
14.58%
Positive 3Y CAGR while JHX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
49.88%
Net income/share CAGR above 1.5x JHX's 8.17% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
9.00%
Below 50% of JHX's 586.41%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-42.91%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.